Javascript must be enabled to continue!
Comparison of Hypertonic Saline with Normal Saline Nebulization in the Management of Bronchiolitis in Children
View through CrossRef
Objective: “To compare the outcome of hypertonic saline with normal saline nebulization in management of bronchiolitis in children” Study design: Randomized controlled trial. Study place and duration: Department of Pediatrics, Hameed Latif Hospital, Lahore from 1st Oct 2024 to 15th April-2025. Methodology: Sixty infants fulfilling selection criteria were enrolled through emergency and were randomly divided in two groups. In group A, infants were given hypertonic (3%) saline nebulization. In group B, infants were given normal saline nebulization. Clinical severity score (CSS) was noted after 30, 60 and 120 minutes of nebulization and change in CSS was calculated. All the data was noted in proforma and analsyed in SPSS v.26. Results: At baseline, the median CSS score was 3.00 (IQR: 0.00) in bob groups, as all the infants has CSS score >2 at the time of presentation / enrolment. The median change after 30 minutes was observed as 1.00 (IQR: 1.00) with hypertonic saline and 1.00 (IQR: 0.25) with normal saline (p<0.05). The median change after 60 minutes was observed as 2.00 (IQR: 1.00) with hypertonic saline and 2.00 (IQR: 1.00) with normal saline (p<0.05). The median change after 120 minutes was observed as 3.00 (IQR: 1.00) with hypertonic saline and 2.00 (IQR: 0.25) with normal saline (p<0.05). Conclusion: The outcomes in terms of reduction in clinical severity score of bronchiolitis with hypertonic saline nebulization is better than normal saline nebulization.
Title: Comparison of Hypertonic Saline with Normal Saline Nebulization in the Management of Bronchiolitis in Children
Description:
Objective: “To compare the outcome of hypertonic saline with normal saline nebulization in management of bronchiolitis in children” Study design: Randomized controlled trial.
Study place and duration: Department of Pediatrics, Hameed Latif Hospital, Lahore from 1st Oct 2024 to 15th April-2025.
Methodology: Sixty infants fulfilling selection criteria were enrolled through emergency and were randomly divided in two groups.
In group A, infants were given hypertonic (3%) saline nebulization.
In group B, infants were given normal saline nebulization.
Clinical severity score (CSS) was noted after 30, 60 and 120 minutes of nebulization and change in CSS was calculated.
All the data was noted in proforma and analsyed in SPSS v.
26.
Results: At baseline, the median CSS score was 3.
00 (IQR: 0.
00) in bob groups, as all the infants has CSS score >2 at the time of presentation / enrolment.
The median change after 30 minutes was observed as 1.
00 (IQR: 1.
00) with hypertonic saline and 1.
00 (IQR: 0.
25) with normal saline (p<0.
05).
The median change after 60 minutes was observed as 2.
00 (IQR: 1.
00) with hypertonic saline and 2.
00 (IQR: 1.
00) with normal saline (p<0.
05).
The median change after 120 minutes was observed as 3.
00 (IQR: 1.
00) with hypertonic saline and 2.
00 (IQR: 0.
25) with normal saline (p<0.
05).
Conclusion: The outcomes in terms of reduction in clinical severity score of bronchiolitis with hypertonic saline nebulization is better than normal saline nebulization.
Related Results
P42 The impact of a change to hospital guidelines on prescribing practices of nebulised 3% w/v ‘hypertonic’ saline
P42 The impact of a change to hospital guidelines on prescribing practices of nebulised 3% w/v ‘hypertonic’ saline
AimsRecent conclusive evidence has suggested that, contrary to previous limited evidence, there is no benefit to the use of 3% hypertonic saline (3% HS) in the treatment of bronchi...
Comparison of nebulised 3% hypertonic saline with ipratropium bromide in treatment of children with bronchiolitis: a randomized control trial
Comparison of nebulised 3% hypertonic saline with ipratropium bromide in treatment of children with bronchiolitis: a randomized control trial
Introduction:
Several drugs are in use for nebulization in children with acute bronchiolitis and no study has yet been conducted to compare the treatment outcome of neb...
Terapi Nebulasi pada Pasien Anak dengan Bronkiolitis
Terapi Nebulasi pada Pasien Anak dengan Bronkiolitis
This study aims to determine which nebulization therapy is effective for improving respiratory status and reducing the length of stay in children with bronchiolitis. The research m...
Efficacy of 3% Hypertonic Saline Nebulization in Acute Bronchiolitis versus Salbutamol Nebulization: A Randomized Controlled Trial
Efficacy of 3% Hypertonic Saline Nebulization in Acute Bronchiolitis versus Salbutamol Nebulization: A Randomized Controlled Trial
Background: Acute bronchiolitis is a leading cause of hospitalization in infants, often managed with bronchodilators and supportive care. Hypertonic Saline (HS) has emerged as a po...
Serum Vitamin D Level in Children With Bronchiolitis
Serum Vitamin D Level in Children With Bronchiolitis
Abstract
Acute bronchiolitis is the most common lower respiratory tract infection during the first year of life. Vitamin D is an important contributing factor to th...
Comparison of hypertonic-saline vs normal-saline nebulization in children with bronchiolitis.
Comparison of hypertonic-saline vs normal-saline nebulization in children with bronchiolitis.
Objective: To compare the efficacy of 3% hypertonic saline (HS) with normal saline (NS) in children with bronchiolitis, in term of change in clinical severity score and duration of...
Chest Wall Hydatid Cysts: A Systematic Review
Chest Wall Hydatid Cysts: A Systematic Review
Abstract
Introduction
Given the rarity of chest wall hydatid disease, information on this condition is primarily drawn from case reports. Hence, this study systematically reviews t...
Study of Efficacy of 3% Hypertonic Saline Nebulisation in Hospitalised Children with Bronchiolitis in Age Group of 2 Months – 24 Months
Study of Efficacy of 3% Hypertonic Saline Nebulisation in Hospitalised Children with Bronchiolitis in Age Group of 2 Months – 24 Months
Background: Bronchiolitis is a common cause of hospitalization in infants under two years, typically caused by RSV. Management is largely supportive. Recent attention has turned to...

